These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8181195)

  • 1. Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics.
    Schwartz JB; Capili H; Daugherty J
    Clin Pharmacol Ther; 1994 May; 55(5):509-17. PubMed ID: 8181195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil.
    Schwartz JB; Troconiz IF; Verotta D; Liu S; Capili H
    J Pharmacol Exp Ther; 1993 May; 265(2):690-8. PubMed ID: 8496816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging alters verapamil elimination and dynamics: single dose and steady-state responses.
    Schwartz JB
    J Pharmacol Exp Ther; 1990 Oct; 255(1):364-73. PubMed ID: 2213568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil stereoisomers during racemic verapamil administration: effects of aging and comparisons to administration of individual stereoisomers.
    Schwartz JB; Capili H; Wainer IW
    Clin Pharmacol Ther; 1994 Oct; 56(4):368-76. PubMed ID: 7955798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age and gender related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil.
    Gupta SK; Atkinson L; Tu T; Longstreth JA
    Br J Clin Pharmacol; 1995 Oct; 40(4):325-31. PubMed ID: 8554934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of age and gender on the stereoselective pharmacokinetics of verapamil.
    Sasaki M; Tateishi T; Ebihara A
    Clin Pharmacol Ther; 1993 Sep; 54(3):278-85. PubMed ID: 8375122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
    Carosella L; Menichelli P; Alimenti M; Zuccala G; Gemma A; Cocchi A; Carbonin PU
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Altered electrocardiographic and hypotensive responses.
    Abernethy DR; Schwartz JB; Todd EL; Luchi R; Snow E
    Ann Intern Med; 1986 Sep; 105(3):329-36. PubMed ID: 3740673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in serum concentrations of and responses to generic verapamil in the elderly.
    Carter BL; Noyes MA; Demmler RW
    Pharmacotherapy; 1993; 13(4):359-68. PubMed ID: 8361862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration.
    Abernethy DR; Wainer IW; Longstreth JA; Andrawis NS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):904-11. PubMed ID: 8355215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of age on the pharmacokinetics of verapamil.
    Ahmed JH; Meredith PA; Elliott HL
    Pharmacol Res; 1991 Oct; 24(3):227-33. PubMed ID: 1956867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose verapamil in middle-aged and elderly patients with angina pectoris: no evidence of increased susceptibility to the cardiac effects.
    Ahmed JH; Elliott HL; Meredith PA; Reid JL
    Cardiovasc Drugs Ther; 1992 Apr; 6(2):153-8. PubMed ID: 1390328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of controlled-release verapamil in healthy volunteers and patients with hypertension or angina.
    Gupta S; Modi NB; Sathyan G; Ho Pl PL; Aarons L
    Biopharm Drug Dispos; 2002 Jan; 23(1):17-31. PubMed ID: 11891670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil pharmacodynamics and disposition in obese hypertensive patients.
    Abernethy DR; Schwartz JB
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):209-15. PubMed ID: 2452316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age on pharmacokinetics and pharmacodynamics in man.
    Klotz U
    Int J Clin Pharmacol Ther; 1998 Nov; 36(11):581-5. PubMed ID: 9849746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of grapefruit juice and smoking on verapamil concentrations in steady state.
    Fuhr U; Müller-Peltzer H; Kern R; Lopez-Rojas P; Jünemann M; Harder S; Staib AH
    Eur J Clin Pharmacol; 2002 Apr; 58(1):45-53. PubMed ID: 11956673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography.
    Toornvliet R; van Berckel BN; Luurtsema G; Lubberink M; Geldof AA; Bosch TM; Oerlemans R; Lammertsma AA; Franssen EJ
    Clin Pharmacol Ther; 2006 Jun; 79(6):540-8. PubMed ID: 16765142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of aging on the pharmacokinetics and pharmacodynamics of doxacurium.
    Gariepy LP; Varin F; Donati F; Salib Y; Bevan DR
    Clin Pharmacol Ther; 1993 Mar; 53(3):340-7. PubMed ID: 8453853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of the enantiomers of verapamil in the dog.
    Bai SA; Lankford SM; Johnson LM
    Chirality; 1993; 5(6):436-42. PubMed ID: 8398603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and pharmacodynamics of d- and dl-verapamil in rabbits.
    Giacomini JC; Nelson WL; Theodore L; Wong FM; Rood D; Giacomini KM
    J Cardiovasc Pharmacol; 1985; 7(3):469-75. PubMed ID: 2410676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.